Krsnaa COVID-19 Diagnostic Services Project

Up to INR400 million from ADB's Ordinary Capital Resources for a secured, non-convertible debenture (NCD) to scale up Krsnaa's coronavirus disease (COVID-19) screening and detection capacity during the COVID-19 pandemic. The project will help (i) purchase reverse transcription polymerase chain reaction (RT-PCR) machines, (ii) purchase test kits and other materials for COVID-19 RT-PCR testing, (iii) purchase computed radiography systems for digital x-ray imaging, (iv) purchase personal protective equipment (PPE), (v) purchase basic hygiene products, (vi) train personnel in infection prevention and control, and (vii) provide general working capital.